2006 related articles for article (PubMed ID: 10071288)
21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
22. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males.
Abalovich M; Levalle O; Hermes R; Scaglia H; Aranda C; Zylbersztein C; Oneto A; Aquilano D; Gutierrez S
Thyroid; 1999 Sep; 9(9):857-63. PubMed ID: 10524563
[TBL] [Abstract][Full Text] [Related]
23. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
24. Gonadal function and fertility in patients with bilateral testicular germ cell malignancy.
Jacobsen KD; Fosså SD; Bjøro TP; Aass N; Heilo A; Stenwig AE
Eur Urol; 2002 Sep; 42(3):229-38; discussion 237-8. PubMed ID: 12234507
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.
Carroll PR; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bajorunas D; Fair WR; Chaganti RS
J Urol; 1987 Mar; 137(3):420-3. PubMed ID: 3029434
[TBL] [Abstract][Full Text] [Related]
26. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio.
Holm M; Rajpert-De Meyts E; Andersson AM; Skakkebaek NE
J Pathol; 2003 Mar; 199(3):378-86. PubMed ID: 12579540
[TBL] [Abstract][Full Text] [Related]
27. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men.
Jensen TK; Andersson AM; Hjollund NH; Scheike T; Kolstad H; Giwercman A; Henriksen TB; Ernst E; Bonde JP; Olsen J; McNeilly A; Groome NP; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Dec; 82(12):4059-63. PubMed ID: 9398713
[TBL] [Abstract][Full Text] [Related]
28. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
29. Compensated reduction in Leydig cell function is associated with lower semen quality variables: a study of 8182 European young men.
Jørgensen N; Joensen UN; Toppari J; Punab M; Erenpreiss J; Zilaitiene B; Paasch U; Salzbrunn A; Fernandez MF; Virtanen HE; Matulevicius V; Olea N; Jensen TK; Petersen JH; Skakkebæk NE; Andersson AM
Hum Reprod; 2016 May; 31(5):947-57. PubMed ID: 26936886
[TBL] [Abstract][Full Text] [Related]
30. Serum inhibin B, FSH, LH and testosterone levels before and after human chorionic gonadotropin stimulation in prepubertal boys with cryptorchidism.
Christiansen P; Andersson AM; Skakkebaek NE; Juul A
Eur J Endocrinol; 2002 Jul; 147(1):95-101. PubMed ID: 12088925
[TBL] [Abstract][Full Text] [Related]
31. Leydig cell function in patients with testicular cancer during and after chemotherapy.
Willemse PH; Sleijfer DT; Schraffordt Koops H; Pratt JJ; Sluiter WJ; Doorenbos H
Int J Androl; 1983 Dec; 6(6):497-508. PubMed ID: 6421750
[TBL] [Abstract][Full Text] [Related]
32. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
33. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
34. Anogenital distance is associated with serum reproductive hormones, but not with semen quality in young men.
Zhou N; Sun L; Yang H; Chen Q; Wang X; Yang H; Tan L; Chen H; Zhang G; Ling X; Huang L; Zou P; Peng K; Liu T; Liu J; Ao L; Zhou Z; Cui Z; Cao J
Hum Reprod; 2016 May; 31(5):958-67. PubMed ID: 27052617
[TBL] [Abstract][Full Text] [Related]
35. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
36. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA
Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
39. Relationships between serum hormone levels and semen quality among men from an infertility clinic.
Meeker JD; Godfrey-Bailey L; Hauser R
J Androl; 2007; 28(3):397-406. PubMed ID: 17135633
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
